Clinical trials
Phase 3 Schizophrenia trials in Brazil
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
25 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 2 |
| 2006 | 2 |
| 2008 | 3 |
| 2010 | 3 |
| 2011 | 2 |
| 2012 | 3 |
| 2014 | 2 |
| 2015 | 1 |
| 2017 | 1 |
| 2021 | 4 |
| 2022 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 19 |
| Terminated | 2 |
| Unknown status | 2 |
| Enrolling by invitation | 1 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Boehringer Ingelheim | 4 |
| Eli Lilly and Company | 3 |
| Alkermes, Inc. | 2 |
| FORUM Pharmaceuticals Inc | 2 |
| Hoffmann-La Roche | 2 |
| Hospital de Clinicas de Porto Alegre | 2 |
| Janssen Research & Development, LLC | 2 |
| AstraZeneca | 1 |
| Denovo Biopharma LLC | 1 |
| Janssen Scientific Affairs, LLC | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Schizophrenia | 25 |
| Psychotic Disorders | 5 |
| Cognition Disorders | 2 |
| Body Weight Changes | 1 |
| Hallucinations | 1 |
| Schizophrenia, Treatment-Resistant | 1 |
Trials
Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.